No one wants to see a bunch of people be treated with something that causes an unexpected serious adverse reaction. Have to start slow and prove the safety.
- Forums
- ASX - By Stock
- PYC
- Ann: Initial Dosing Completed in Cohort 1 of RP11 MAD Study
Ann: Initial Dosing Completed in Cohort 1 of RP11 MAD Study, page-5
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $513.2M |
Open | High | Low | Value | Volume |
11.0¢ | 11.0¢ | 11.0¢ | $21.29K | 193.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 760165 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 388514 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 760165 | 0.105 |
22 | 1806204 | 0.100 |
1 | 5100 | 0.098 |
1 | 50000 | 0.096 |
8 | 232819 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 388514 | 7 |
0.115 | 1267776 | 9 |
0.120 | 731900 | 4 |
0.125 | 722274 | 8 |
0.130 | 1947951 | 11 |
Last trade - 10.37am 24/07/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online